
Liked By
Spread the love. Be the first to like this post!
Recent VBIV News
- Annual Report (10-k) • Edgar (US Regulatory) • 03/13/2023 12:02:30 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 12:01:23 PM
- VBI Vaccines Reports Full Year 2022 Financial Results • Business Wire • 03/13/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/28/2023 06:03:25 PM
- VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat • Business Wire • 02/23/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/15/2023 01:01:54 PM
- VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B • Business Wire • 02/15/2023 01:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:06:14 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:05:25 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:04:34 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:44 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:44 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:20 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/30/2022 10:01:27 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/27/2022 01:02:11 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/08/2022 01:01:18 PM
- VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults • Business Wire • 12/08/2022 01:00:00 PM
- CEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI Vaccines Deal • Business Wire • 12/06/2022 02:25:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/22/2022 01:00:59 PM
- VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting • Business Wire • 11/22/2022 01:00:00 PM
- VBI Vaccines to Participate in Upcoming Investor Conferences • Business Wire • 11/14/2022 01:00:00 PM
- VBI Vaccines Announces Presentation of Data from Ongoing Phase 2a Study of VBI-1901 at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting • Business Wire • 11/11/2022 01:00:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:01:59 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:01:29 PM
- VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update • Business Wire • 11/10/2022 01:00:00 PM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
PSYC's CEO to Moderate Panel at Film Screening for ESPN's Upcoming Documentary, "Peace of Mind" • PSYC • Mar 29, 2023 8:30 AM
Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • USHA • Mar 28, 2023 8:26 AM
Edison Lithium Provides Update on Spin-Out of Cobalt Assets • EDDY • Mar 28, 2023 8:09 AM
Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • EPAZ • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM